| __timestamp | Galapagos NV | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 9335772 |
| Thursday, January 1, 2015 | 129714000 | 999000 |
| Friday, January 1, 2016 | 139574000 | 978000 |
| Sunday, January 1, 2017 | 218502000 | 952000 |
| Monday, January 1, 2018 | 322876000 | 956000 |
| Tuesday, January 1, 2019 | 427320000 | 8122999 |
| Wednesday, January 1, 2020 | 523667000 | 8712000 |
| Friday, January 1, 2021 | 1629000 | 13980000 |
| Saturday, January 1, 2022 | 12079000 | 21135000 |
| Sunday, January 1, 2023 | 35989000 | 10755000 |
Infusing magic into the data realm
In the ever-evolving biotech industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Iovance Biotherapeutics, Inc. and Galapagos NV from 2014 to 2023. Over this period, Galapagos NV experienced a significant fluctuation, with costs peaking in 2020 at over 500% of their 2014 levels, before dropping sharply in 2021. Meanwhile, Iovance Biotherapeutics, Inc. maintained a more stable trajectory, with costs increasing modestly by approximately 14% over the same period. Notably, 2022 marked a pivotal year for Iovance, with costs surging by 50% compared to the previous year. These insights highlight the dynamic nature of cost management in the biotech sector, offering a window into the strategic financial decisions of these companies.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Galapagos NV
Cost Insights: Breaking Down Johnson & Johnson and Iovance Biotherapeutics, Inc.'s Expenses
Cost of Revenue Trends: Pfizer Inc. vs Iovance Biotherapeutics, Inc.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs Iovance Biotherapeutics, Inc.
Cost of Revenue: Key Insights for GSK plc and Galapagos NV
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Galapagos NV
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Galapagos NV
Halozyme Therapeutics, Inc. vs Galapagos NV: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Galapagos NV
Cost of Revenue Comparison: Amneal Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
MorphoSys AG vs Iovance Biotherapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Iovance Biotherapeutics, Inc. vs Viridian Therapeutics, Inc.